Skip to Main Content

Advertisement

Skip Nav Destination

Impact of allogeneic stem cell transplantation on survival of patients less than 65 years of age with primary myelofibrosis

Blood (2015) 125 (21): 3347–3350.
Currently there are no citedby results. Try again later.
Close Modal

or Create an Account

Close Modal
Close Modal

Advertisement